Trial Profile
Efficacy of palbociclib in patients with hormone receptor positive metastatic breast cance: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2019
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary) ; Aromatase inhibitors; Fulvestrant; Letrozole
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology